Guidelines-and-forms

in page functions

24 May 2016

Guidelines on reporting and renewals in 2016 for all types of support

These guidelines provide guidance on the reporting process and requirements for all types of Gavi support. They also provide guidance on how a country requests renewal of support.

04 April 2016

Product Switch Budget Template

Budget template for product and/or presentation switches for Gavi-supported vaccines. This document is intended to be used by countries applying for a Gavi product switch grant. [French] [Spanish] [Russian] 

04 April 2016

PCV 4-dose vials FAQs

Frequently asked questions on the 4-dose vials of pneumococcal conjugate vaccines. [French] [Spanish] [Russian] 

25 February 2016

How to plan and conduct a joint appraisal

This guidance is intended for country stakeholders, alliance partners and Gavi Secretariat staff involved in planning and conducting the joint appraisal. This document explains the purpose and objectives of the joint appraisal and outlines suggested steps to organize a successful appraisal process.

25 February 2016

Frequently asked questions about the joint appraisal

Frequently asked questions about the joint appraisal.

25 February 2016

How to develop the joint appraisal report

This document accompanies the “Joint Appraisal Report Template” (Word file) and provides guidance to the joint appraisal team on how to develop the report. The content provided in each section of this document is intended to guide the appraisal discussions to ensure the relevant range of issues is covered in the appraisal and is sufficiently addressed in the final report.

01 January 2016

Guidance on financial reporting

Gavi Financial Management & Audit Requirements outline the principles and requirements for recipients of Gavi support applicable as of 1st January 2016. Accompanying these guidelines are a set of templates and examples for use.

18 December 2015

CCE Platform Application Instructions

Instructions for the CCE Optimisation Platform Application.

20 October 2015

Performance Framework Overview

An overview of the definition, content, use and introduction of the performance framework.

16 October 2015

MCV2 & MR guidelines

Specific guidelines on applications for measles second dose and measles-rubella vaccines under Gavi’s new and underused vaccine support (NVS).

16 October 2015

YF guidelines

Specific guidelines on applications for yellow fever vaccines under Gavi’s new and underused vaccine support (NVS).

16 October 2015

Pneumo FAQ

Frequently asked questions on support for pneumococcal conjugate vaccines.

16 October 2015

HSS guidelines

Support-specific guidelines for health system strengthening (HSS) support, which provide specific information on the type of support Gavi provides and any specific requirements and related guidance for developing an application.

16 October 2015

Pneumo guidelines

Specific guidelines on applications for pneumococcal conjugate vaccines under Gavi’s new and underused vaccine support (NVS).

16 October 2015

HSS application instructions

Presents detailed guidance on how to complete the HSS application form, and should be read prior and during completion of the form.

16 October 2015

General Guidelines

General Guidelines document for all types of Gavi support, which provides an introduction to Gavi and the types of support provided, information on country eligibility for accessing support, the application process and grant cycle as a whole as well as Gavi’s overarching approach/ requirements for country support.

16 October 2015

JE guidelines

Specific guidelines on applications for Japanese encephalitis vaccines under Gavi’s new and underused vaccine support (NVS).

16 October 2015

HPV FAQ

Frequently asked questions on support for human papillomavirus (HPV) vaccines.

16 October 2015

Rotavirus guidelines

Specific guidelines on applications for rotavirus vaccines under Gavi’s new and underused vaccine support (NVS).

16 October 2015

Rotavirus FAQ

Frequently asked questions on support for rotavirus vaccines.

16 October 2015

MenA guidelines

Specific guidelines on applications meningococcal A conjugate vaccines under Gavi’s new and underused vaccine (NVS) Support.

16 October 2015

HSS FAQ

Frequently asked questions on support for health system strengthening support.

16 October 2015

NVS application instructions

Presents detailed guidance on how to complete the NVS application form, and should be read prior and during completion of the form.

16 October 2015

HPV demo guidelines

Specific guidelines on applications for HPV vaccine demonstration programmes under Gavi’s new and underused vaccine support (NVS).

16 October 2015

YF FAQ

Frequently asked questions on support for yellow fever vaccines.

16 October 2015

JE FAQ

Frequently Asked Questions on support for Japanese encephalitis (JE) vaccines.

16 October 2015

MenA FAQ

Frequently asked questions on support for meningococcal A conjugate vaccines.

16 October 2015

HPV national guidelines

Specific guidelines on applications for human papillomavirus (HPV) vaccines for national introduction under Gavi’s new and underused vaccine support (NVS).

16 October 2015

IRC Review Criteria for 2016

The criteria used by the Independent Review Committee (IRC) to assess applications.

16 October 2015

MCV2 & MR FAQ

Frequently asked questions on support for measles second dose and measles-rubella vaccines.

15 October 2015

Guidelines - Exceptional opportunity to apply for HPV vaccine support

In June 2015 the Gavi Board decided to grant a subset of countries the one-time opportunity to apply for catalytic support for HPV vaccine introduction to countries that have not had the opportunity to apply due to the recent addition of this vaccine to the Gavi portfolio. These guidelines provide all necessary information to apply for this exceptional support.

15 October 2015

Guidelines - Exceptional opportunity to apply for MR vaccine support

In June 2015 the Gavi Board decided to grant a subset of countries the one-time opportunity to apply for catalytic support for MR vaccine introduction to countries that have not had the opportunity to apply due to the recent addition of this vaccine to the Gavi portfolio. These guidelines provide all necessary information to apply for this exceptional support.

15 October 2015

Guidelines - Exceptional opportunity to apply for JE vaccine support

In June 2015 the Gavi Board decided to grant a subset of countries the one-time opportunity to apply for catalytic support for JE vaccine introduction to countries that have not had the opportunity to apply due to the recent addition of this vaccine to the Gavi portfolio. These guidelines provide all necessary information to apply for this exceptional support.

09 September 2015

Guidance on evaluation of HSS grants

Information on independent evaluations of Gavi HSS grants.

09 September 2015

2015-2016 Gavi HSS Country Ceilings

Gavi’s total funding envelope for each country.

09 September 2015

Co-financing default

Information on what happens when a country does not fulfil its co-financing requirement on time.

09 September 2015

Guidance on grant modification for fragile countries

Information on when countries in emergency situations or with exceptional challenges may be eligible for additional flexibilities under the Fragility and Immunisation Policy.

09 September 2015

Guidance for developing vaccine introduction plans

Guidance on completing new vaccine introduction operational plans and a Plan of Action.

09 September 2015

Guidance on investments with high impact potential

Information on bottlenecks and associated activities that have been determined to have a high potential impact on immunisation outcomes.

09 September 2015

HPV resources

Links to useful resources for more information on the HPV vaccine.

21 August 2015

FAQ - Civil Society Access to GAVI Pricing for Vaccines

1 Civil society access to GAVI pricing for vaccines Frequently asked questions September 2013 1. Does GAVI support the delivery of immunisation services by civil society organisations? GAVI recognises the key role that civil society organisations (CSOs) play in the national immunisation programmes of many countries. 2.

03 August 2015

Gavi's grant application, monitoring and review redesign

Overview of how Gavi is enhancing its routine grant monitoring and reporting.

30 June 2015

FAQ - Grant management change process

The Gavi Alliance grant management change process Frequently asked questions May 2015 Overall change process 1. How was it decided that grant management changes were needed? Over recent years, through a series of consultation sessions, the Gavi Alliance Board, Programme and Policy Committee (PPC), partners, countries,

22 December 2014

Gavi and Ebola - FAQ

Gavi and Ebola - Frequently asked questions.

18 August 2014

GAVI HSS Grant Categorisation 2014

This table is intended to provide ideas of HSS activities to applicants and to allow GAVI to analyse its HSS support by type of grants.

01 July 2014

GNI per capita 2013

Gross national income per capita 2013.

31 March 2014

HSS Country ceilings

Country ceilings and maximum annual amounts for budgeting for GAVI Health Systems Strengthening (HSS) grant applications.

10 March 2014

Delivering results in HSS information sheet

Information sheet about measuring results for health system performance and improving data quality.

10 March 2014

Guidance on GAVI HSS approach and application process

Health system strengthening approach information sheet.

10 March 2014

Performance Based Funding information sheet

Information sheet about GAVI’s HSS Performance Based Funding.

10 March 2014

Human Papillomavirus vaccines information sheet

Human Papillomavirus vaccines information sheet.

10 March 2014

Japanese Encephalitis vaccines FAQ

Japanese Encephalitis vaccines Frequently Asked Questions.

14 June 2013

Frequently asked questions about Gavi's co-financing

Frequently asked questions about co-financing.

26 March 2013

Request form for emergency response

As outlined in the GAVI policy on fragility and immunisation, GAVI will provide one-off flexibilities in order to help protect immunisation systems and existing GAVI support in countries experiencing time-limited emergencies. This form is developed to assist countries in such emergency circumstances wanting to apply for these flexibilities.

22 March 2013

CSO Implementation and Results Framework

The GAVI Board has decided that HSS will be the single window for GAVI cash grants. GAVI support for CSOs will be part of a country Health Systems Strengthening (HSS) proposal to improve immunisation outcomes. The document presents why and how GAVI works with and supports CSOs in programme implementation.

12 September 2012

HSS Policy Timeline

Health System Strengthening (HSS) Policies and Major Decisions at GAVI Timeline and Overview.

 



close icon

modal window here